Diabetes Care:经皮氧分压可预测糖尿病患者心血管风险

2013-02-26 Diabetes Care CDS糖尿病在线

  意大利学者进行的一项研究提示,经皮氧分压(TcPO2)是无合并症2型糖尿病患者主要不良心脏事件(MACE)风险的潜在预测指标,且预测价值似乎高于踝臂指数(ABI)。研究于2013年2月12日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究入选361例无合并症的2型糖尿病患者,随访45.8个月期间共发生67例MACE。研究者报告,发生MACE的受试者中ABI(≤0.9)

  意大利学者进行的一项研究提示,经皮氧分压(TcPO2)是无合并症2型糖尿病患者主要不良心脏事件(MACE)风险的潜在预测指标,且预测价值似乎高于踝臂指数(ABI)。研究于2013年2月12日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  该研究入选361例无合并症的2型糖尿病患者,随访45.8个月期间共发生67例MACE。研究者报告,发生MACE的受试者中ABI(≤0.9)和TcPO2(≤46 mm Hg)均降低者的比例较未发生MACE者明显增加(ABI:64.2% vs. 40.8%;TcPO2:58.2% vs. 34%)。Kaplan-Meier分析表明,ABI或TcPO2降低均与MACE风险增加有关。Cox回归分析证实,只有TcPO2降低可显著预测MACE的发生(HR=1.78,P<0.001)。


Transcutaneous Oxygen Tension As a Potential Predictor of Cardiovascular Events in Type 2 Diabetes

Comparison with ankle-brachial index

OBJECTIVE 

Transcutaneous oxygen tension (TcPO2) measures tissue perfusion and is important in the management of peripheral artery disease (PAD). Ankle brachial index (ABI) is used for the diagnosis of PAD and represents a predictor of major adverse cardiovascular events (MACE), even if in diabetes its diagnostic and predictive value seems to be reduced. No study has evaluated TcPO2 as a predictor of cardiovascular events. Aim of this longitudinal study was to assess whether TcPO2 is better than ABI at predicting MACE in type 2 diabetic patients.

RESEARCH DESIGN AND METHODS 

Among 361 consecutive patients with apparently uncomplicated diabetes, 67 MACE occurred during a follow-up period of 45.8 ± 23.2 months.

RESULTS 

The percentage of both subjects with low ABI (≤0.9) and subjects with low TcPO2 (≤46 mmHg as measured by a receiver operating characteristic curve) was significantly (<0.001) greater among patients with than among those without MACEs (ABI 64.2 vs. 40.8; TcPO2 58.2 vs. 34%). The Kaplan-Meier method showed that both low ABI (Mantel log-rank test, 4.087; P = 0.043) and low TcPO2 (Mantel log-rank test, 33.748; P > 0.0001) were associated with a higher rate of MACEs. Cox regression analysis showed that low TcPO2 (hazard ratio 1.78 [95% CI 1.44–2.23]; P < 0.001) was a significant predictor of MACE, while ABI did not enter the model.

CONCLUSIONS 

This longitudinal study showed that TcPO2 may be a potential predictor of MACE among patients with uncomplicated type 2 diabetes and that its predictive value seems to be greater than that of ABI.



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901050, encodeId=b156190105065, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Nov 28 13:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082329, encodeId=95142082329c9, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Oct 24 15:38:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759243, encodeId=c9f71e5924354, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jan 02 13:38:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636626, encodeId=60cf163662683, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Aug 24 11:38:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473685, encodeId=450a14e3685fa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901050, encodeId=b156190105065, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Nov 28 13:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082329, encodeId=95142082329c9, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Oct 24 15:38:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759243, encodeId=c9f71e5924354, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jan 02 13:38:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636626, encodeId=60cf163662683, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Aug 24 11:38:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473685, encodeId=450a14e3685fa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901050, encodeId=b156190105065, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Nov 28 13:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082329, encodeId=95142082329c9, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Oct 24 15:38:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759243, encodeId=c9f71e5924354, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jan 02 13:38:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636626, encodeId=60cf163662683, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Aug 24 11:38:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473685, encodeId=450a14e3685fa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901050, encodeId=b156190105065, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Nov 28 13:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082329, encodeId=95142082329c9, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Oct 24 15:38:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759243, encodeId=c9f71e5924354, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jan 02 13:38:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636626, encodeId=60cf163662683, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Aug 24 11:38:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473685, encodeId=450a14e3685fa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1901050, encodeId=b156190105065, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Nov 28 13:38:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082329, encodeId=95142082329c9, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Oct 24 15:38:00 CST 2013, time=2013-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759243, encodeId=c9f71e5924354, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jan 02 13:38:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636626, encodeId=60cf163662683, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Aug 24 11:38:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473685, encodeId=450a14e3685fa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]

相关资讯

Diabetes Care:糖尿病增高骨折相关住院风险

  2012年12月17日在线发表于《糖尿病护理》(Diabetes Care )的一项研究显示,被确诊为糖尿病的成年人,其骨折相关住院风险明显升高。   该研究由美国马里兰州巴尔的摩市约翰斯·霍普金斯大学Bloomberg公共卫生学院流行病学系的Andrea L.C. Schneider极其同事完成,是一项基于社区的大型研究。研究者表示,这一结果支持美国糖尿病学会在合适的患者人群中评估骨折风险

Diabetes Care:LOGIC-Insulin算法指导强化血糖控制效果佳

  来自荷兰鲁汶大学的一项前瞻性、平行组、随机对照临床试验显示,应用计算机软件程序LOGIC-Insulin实施强化血糖控制(TGC)的效能优于经验丰富的护士,且不增加低血糖事件的发生率。该研究2013年2月在线发表在《糖尿病护理》杂志(Diabetes care)上。   对危重患者实施TGC较为困难,且工作强度大,导致血糖控制效果不佳和低血糖发生率增加。LOGIC-Insul

DIABETES RES CLIN PR:糖尿病显著增加抑郁风险

  意大利的一项荟萃研究提示,糖尿病与抑郁风险显著增加相关。文章认为糖尿病与抑郁症相关的病理机制值得进一步探讨。相关论文2012年12月26日在线发表于《糖尿病研究与临床实践》杂志(Diabetes Research and Clinical Practice)。   该荟萃研究使用关键词“糖尿病和抑郁或糖尿病和抗抑郁药”检索Medline,选择那些

Lancet:糖尿病和肥胖或致巨大儿增多

  一项横断面研究显示,育龄女性糖尿病和肥胖发病率升高与巨大儿出生增多平行相关。论文2013年1月4日在线发表于《柳叶刀》(Lancet)杂志。   研究分析了276436次单胎活产或新发死产,结果表明产妇年龄较大(20~34岁)、身材较高、产次较多、体质指数较高、患糖尿病、过期妊娠及男性胎儿,均与巨大儿发生危险的显著增加相关。巨大儿与因难产和过期妊娠而引发剖宫产,以及孕产妇分娩不良转归的危险增

JGIM:血糖达标非糖尿病患者心血管获益关键

  一项纳入2.6万余例受试者的观察性研究显示,对于2型糖尿病患者,收缩压(SBP,<130 mm Hg)或低密度脂蛋白胆固醇(LDL-C,<100 mg/dl)达标与心血管疾病(CVD)住院风险的降低显著相关,而糖化血红蛋白(HbA1c)达标(<7%)并不是CVD住院风险降低的独立因素。(J Gen Intern Me

JAMA Intern Med:普通健康体检未能降低死亡率

  丹麦学者的一项荟萃分析综述表明,普通健康体检未能降低总体死亡率。该综述1月14日在线发表于《JAMA内科学》(JAMA Intern Med)。   此项荟萃分析共纳入14项于1963至1999年间实施的随机对照试验,并评估了年度体检对发病率和死亡率的影响。以仅用于预防咨询和筛查的就诊定义普通体检,排除慢性病治疗或紧急救护所引发的就诊。纳入试验共涉及182,000余例患者